Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05184660 · ClinicalTrials.gov registry record
Smart Eyewear to Automatically Detect Drug Delivery Events
A clinical trial of Smart Eyewear, sponsored by University of Washington.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05184660: Recruiting study of Smart Eyewear, sponsored by University of Washington.
NCT05184660 is a study of Smart Eyewear that is actively recruiting participants, run by University of Washington. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05184660, a study of Smart Eyewear, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed as a prospective observational study of medication preparation and delivery using a novel wearable data input device to automate detection of drug delivery events in the anesthesia workspace at University of Washington Medical Center.
Primary Outcome
Operating room footage of drug preparation and drug delivery events recorded by anesthesia provider using a point-of-view device.
Conditions Studied
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2026-12-01 |
What NCT05184660 shows while recruiting
NCT05184660 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Smart Eyewear appearing as the primary indexed condition, and to 0 interventions.
NCT05184660 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05184660 about?
NCT05184660 is a clinical study titled "Smart Eyewear to Automatically Detect Drug Delivery Events". This project is designed as a prospective observational study of medication preparation and delivery using a novel wearable data input device to automate detection of drug delivery events in the anesthesia workspace at University of Washington Medical Center.
What is the current status of trial NCT05184660?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2021-01-04. Estimated completion is 2026-12-01.
What conditions does trial NCT05184660 study?
This clinical trial studies the following conditions: Smart Eyewear.
Who is sponsoring clinical trial NCT05184660?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05184660 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI